Aptamer Group PLC (APTA) - Total Assets

Latest as of June 2025: GBX2.83 Million GBX ≈ $344.82 USD

Based on the latest financial reports, Aptamer Group PLC (APTA) holds total assets worth GBX2.83 Million GBX (≈ $344.82 USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Aptamer Group PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Aptamer Group PLC - Total Assets Trend (2019–2025)

This chart illustrates how Aptamer Group PLC's total assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Aptamer Group PLC to evaluate the tangible quality of the company's equity base.

Aptamer Group PLC - Asset Composition Analysis

Current Asset Composition (June 2025)

Aptamer Group PLC's total assets of GBX2.83 Million consist of 64.3% current assets and 35.7% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 37.4%
Accounts Receivable GBX532.00K 18.8%
Inventory GBX80.00K 2.8%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX225.00K 7.9%
Goodwill GBX0.00 0.0%

Asset Composition Trend (2019–2025)

This chart illustrates how Aptamer Group PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Aptamer Group PLC market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Aptamer Group PLC's current assets represent 64.3% of total assets in 2025, a decrease from 88.4% in 2019.
  • Cash Position: Cash and equivalents constituted 37.4% of total assets in 2025, down from 52.1% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 1.0% in 2019.
  • Asset Diversification: The largest asset category is accounts receivable at 18.8% of total assets.

Aptamer Group PLC Competitors by Total Assets

Key competitors of Aptamer Group PLC based on total assets are shown below.

Company Country Total Assets
Revolution Medicines Inc
NASDAQ:RVMD
USA $2.25 Billion
Tubize-Fin
BR:TUB
Belgium €1.93 Billion
Metsera, Inc. Common Stock
NASDAQ:MTSR
USA $639.66 Million
Hugel Inc
KQ:145020
Korea ₩1.13 Trillion
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
USA $553.60 Million
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
China CN¥6.82 Billion
Absci Corp
NASDAQ:ABSI
USA $195.59 Million
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880
China CN¥3.67 Billion

Aptamer Group PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.55 1.27 2.58
Quick Ratio 1.48 1.17 2.45
Cash Ratio 0.00 0.00 0.00
Working Capital GBX647.00K GBX340.00K GBX755.23K

Aptamer Group PLC - Advanced Valuation Insights

This section examines the relationship between Aptamer Group PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 17.56
Latest Market Cap to Assets Ratio 0.06
Asset Growth Rate (YoY) 2.3%
Total Assets GBX2.83 Million
Market Capitalization $172.28K USD

Valuation Analysis

Below Book Valuation: The market values Aptamer Group PLC's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Aptamer Group PLC's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Aptamer Group PLC (2019–2025)

The table below shows the annual total assets of Aptamer Group PLC from 2019 to 2025.

Year Total Assets Change
2025-06-30 GBX2.83 Million
≈ $344.82
+2.35%
2024-06-30 GBX2.77 Million
≈ $336.91
+0.58%
2023-06-30 GBX2.75 Million
≈ $334.96
-76.10%
2022-06-30 GBX11.52 Million
≈ $1.40K
+458.14%
2021-06-30 GBX2.06 Million
≈ $251.13
+48.51%
2020-03-31 GBX1.39 Million
≈ $169.09
-0.53%
2019-03-31 GBX1.40 Million
≈ $169.99
--

About Aptamer Group PLC

LSE:APTA UK Biotechnology
Market Cap
$172.28K
GBX1.42 Billion GBX
Market Cap Rank
#31155 Global
#1039 in UK
Share Price
GBX0.53
Change (1 day)
+10.53%
52-Week Range
GBX0.32 - GBX1.30
All Time High
GBX153.00
About

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and … Read more